1 Min Read
March 16 (Reuters) - Mabvax Therapeutics Holdings Inc
* Offering 5.1 million shares of common stock at a public offering price of $2.92 per share - SEC filing Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.